Sequential or concurrent tamoxifen and radiotherapy: To see or not to see - That is the question! [9]

Journal of Clinical Oncology

Volumn 23, Issue 25, 2005, Pages 6266-6267

  Bentzen, Søren M ^a   Yarnold, John R ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; LETTER; PRIORITY JOURNAL; RADIOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; BREAST TUMOR; DRUG ADMINISTRATION; FEMALE; META ANALYSIS; MULTIMODALITY CANCER THERAPY; NOTE; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; META-ANALYSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; TAMOXIFEN; TREATMENT OUTCOME;

EID: 24944434696     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.5040     Document Type: Letter

References (11)

1. Pierce LJ, Hutchins LF, Green SR, et al: Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer. J Clin Oncol 23:24-29, 2005
2. Ahn PH, Vu HT, Lannin D, et al: Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates. J Clin Oncol 23:17-23, 2005
3. Harris EE, Christensen VJ, Hwang WT, et al: Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol 23:11-16, 2005
4. Whelan T, Levine M: Radiation therapy and tamoxifen: Concurrent or sequential? That is the question. J Clin Oncol 23:1-4, 2005
5. Bentzen SM: A user's guide to evidence-based oncology. Eur J Cancer Supplements 1:77-91, 2003 (suppl 6)
6. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 351:1451-1467, 1998
7. Bentzen SM, Skoczylas JZ, Overgaard M, et al: Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 88:918-922, 1996
8. Von Pfeil A, Hakenjos L, Herskind C, et al: Irradiated homozygous TGF-beta1knockout fibroblasts show enhanced clonogenic survival as compared with TGF-beta1 wild-type fibroblasts. Int J Radiat Biol 8:331-339, 2002
9. Ahmed MM, Alcock RA, Chendil D, et al: Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/ Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2. J Biol Chem 277:2234-2246, 2002
10. Vodovotz Y, Lucia MS, DeLucca AM, et al: Reduced hematopoietic function and enhanced radiosensitivity of transforming growth factor-beta1 transgenic mice. Int J Cancer 90:13-21, 2000
11. Kim AH, Lebman DA, Dietz CM, et al: Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33. Int J Oncol 23:1593-1599, 2003